I. - Basic information

I.1 - Surname

Valášková

I.2 - Name

Simona

I.3 - Degrees

PharmDr., PhD.

I.4 - Year of birth

1985

I.5 - Name of the workplace

Institute of Pharmacology and Clinical Pharmacology

I.6 - Address of the workplace

Sasinkova 4, 811 08 Bratislava

I.7 - Position

Research Specialist

I.8 - E-mail address

valaskova7@uniba.sk

I.10 - Name of the study field in which a person works at the university

pharmacology

I.11 - ORCID iD

0000-0003-2946-4071

II. - Higher education and further qualification growth

II.1 - First degree of higher education

II.2 - Second degree of higher education

II.a - Name of the university or institution

Faculty of Pharmacy, Comenius University in Bratislava

II.b - Year

2009

II.3 - Third degree of higher education

II.a - Name of the university or institution

Faculty of Pharmacy, Comenius University in Bratislava

II.b - Year

2021

II.c - Study field and programme

pharmacology

II.4 - Associate professor

II.5 - Professor

II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position	III.b - Institution	III.c - Duration
Research Specialist	V. Department of Internal Medicine,	2024-2025
Research Specialist	International Laser Centre SCSTI	2024-2025
Research Specialist	Slovak Centre of Scientific and Technical Information (SCSTI)	2021-2023

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other	IV.b - Name of the institution	IV.c - Year
Certificate of professional competence for work with very toxic substances and mixtures and toxic substances and mixtures	Regional Public Health Authority in Bratislava	2025
Recognized Scientific - qualification level IIa	Slovak Academy of Sciences	2024

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes

V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year

V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year

V.4 - Overview of supervised final theses

V.4.1 - Number of currently supervised theses

V.4.b - Diploma (second degree)

Pharmacology of modern antidiabetic drugs Student: Martina Šabová; Efficacy of hypolipidemic drugs in clinical practice Student: Kristína Šašová

V.4.2 - Number of defended theses

V.5 - Overview of other courses taught in the current academic year according to study programmes

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations

VI.1.1 - Number of the research/artistic/other outputs

VI.1.a - Overall

VI.1.b - Over the last six years

VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases

VI.1.a - Overall

VI.1.b - Over the last six years

VI.1.3 - Number of citations corresponding to the research/artistic/other outputs

VI.1.a - Overall

186

VI.1.b - Over the last six years

186

VI.1.4 - Number of citations registered in the Web of Science or Scopus databases

VI.1.a - Overall

VI.1.b - Over the last six years

VI.1.5 - Number of invited lectures at the international, national level

VI.2 - The most significant research/artistic/other outputs

Valášková S, Gažová A, Vrbová P, Koller T, Šalingova B, Adamičková A, Chomaničová N, Hulajová N, Payer J, Kyselovič J. The Severity of Muscle Performance Deterioration in Sarcopenia Correlates With Circulating Muscle Tissue-Specific miRNAs. Physiol Res. 2021 Nov 30;70(Suppl 1):S91-S98. PMID: 35503054.

Valášková S, Kyselovič J, Gažová A. Selective inhibitors of cyclooxygenase 2 - their past, present and future. Ceska Slov Farm. 2023 Spring;72(2):63-69. English. PMID: 37211426.

Kyselovic J, Adamičková A, Gažová A, Valášková S, Chomaničová N, Červenák Z, Madaric J. Atorvastatin Treatment Significantly Increased the Concentration of Bone Marrow-Derived Mononuclear Cells and Transcutaneous Oxygen Pressure and Lowered the Pain Scale after Bone Marrow Cells Treatment in Patients with "No-Option" Critical Limb Ischaemia. Biomedicines. 2024 Apr 22;12(4):922. doi: 10.3390/biomedicines12040922. PMID: 38672276; PMCID: PMC11048671.

Adamickova, A., Chomanicova, N., Adamicka, M., Valaskova, S., Gazova, A., Kyselovic, J. (2024). Isolation and Characterization of Human Dental Pulp Stem Cells Derived from Dental Pulp of Permanent Teeth. In: Di Nardo, P., Dhingra, S., Desiderio, V. (eds) Adult Stem Cells. Methods in Molecular Biology, vol 2835. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3995-5_5

Chomanicova N, Adamickova A, Valaskova S, Gazova A, Kyselovic J. Caco-2 Monolayer as a Model of the Intestinal Barrier: Permeability of Magnesium Salts. Methods Mol Biol. 2024;2835:301-306. doi: 10.1007/978-1-0716-3995-5_25. PMID: 39105925

VI.3 - The most significant research/artistic/other outputs over the last six years

Adamičková A, Kyselovic J, Adamička M, Chomaničová N, Valášková S, Šalingová B, Molitorisová M, Červenák Z, Danišovič Ľ, Gažová A. Effects of Ibuprofen and Diclofenac Pre-Treatment on Viability and Apoptosis Processes in Human Dental Pulp Stem Cells. Medicina (Kaunas). 2024 May 9;60(5):787. doi: 10.3390/medicina60050787. PMID: 38792973; PMCID: PMC11123081.

VI.4 - The most significant citations corresponding to the research/artistic/other outputs

The pi3k/Akt Pathway Is Associated With Angiogenesis, Oxidative Stress and Survival of Mesenchymal Stem Cells in Pathophysiologic Condition in Ischemia Samakova, A (Samakova, A.) [1] ; Gazova, A (Gazova, A.) [2] ; Sabova, N (Sabova, N.) [1] ; Valaskova, S (Valaskova, S.) [1] ; Jurikova, M (Jurikova, M.) [3] ; Kyselovic, J (Kyselovic, J.) [4]; PHYSIOLOGICALRESEARCH;Volume68PageS131-S138Supplement2; DOI10.33549/physiolres.934345; 2019; 171 citácií

The Role of AMPK/mTOR Signaling Pathway in Anticancer Activity of Metformin Chomanicova, N (Chomanicova, Nikola) [1] ; Gazova, A (Gazova, Andrea) [2] ; Adamickova, A (Adamickova, Adriana) [3] ; Valaskova, S (Valaskova, Simona) [1] ; Kyselovic, J (Kyselovic, Jan) [3]; PHYSIOLOGICAL RESEARCH; Volume70Issue4Page501-508; DOI10.33549/physiolres.934618, AUG 2021; 57 citácií

Clinical study of effectiveness and safety of CELcomplex® containing Cucurbita Pepo Seed extract and Flax and Casuarina on stress urinary incontinence in women Gazová, A (Gazova, Andrea) [1] ; Valásková, S (Valaskova, Simona) [2] ; Zufková, V (Zufkova, Viera) [2] ; Castejon, AM (Castejon, Ana M.) [3] ; Kyselovic, J (Kyselovic, Jan) [2] , [4]; JOURNAL OF TRADITIONAL AND COMPLEMENTARY MEDICINE;Volume9Issue2Page138-142;DOI10.1016/j.jtcme.2017.10.005; APR 2019; 25 citácií

The Severity of Muscle Performance Deterioration in Sarcopenia Correlates With Circulating Muscle Tissue-Specific miRNAs Valasková, S (Valaskova, Simona) [1] ; Gazová, A (Gazova, Andrea) [2] ; Vrbová, P (Vrbova, Petra) [3] ; Koller, T (Koller, Tomas) [3] ; Salingova, B (Salingova, Barbara) [3] ; Adamicková, A (Adamickova, Adriana) [3] ; Chomanicová, N (Chomanicova, Nikola) [1] ; Hulajová, N (Hulajova, Nikoleta) [4] ; Payer, J (Payer, Juraj) [3] ; Kyselovic, J (Kyselovic, Jan) [3]; PHYSIOLOGICAL RESEARCH; Volume70PageS91 S98Supplement1; DOI10.33549/physiolres.934778; NOV 2021; 17 citácií

Endothelial-Mesenchymal Transition or Functional Tissue Regeneration - Two Outcomes of Heart Remodeling Salingova, B (Salingova, Barbara) [1] ; Cervenak, Z (Cervenak, Zdenko) [1] ; Adamicková, A (Adamickova, Adriana) [1] ; Chromanicová, N (Chromanicova, Nikola) [2] ; Valasková, S (Valaskova, Simona) [2] ; Gazová, A (Gazova, Andrea) [2] ; Kyselovic, J (Kyselovic, Jan) [1]; PHYSIOLOGICAL RESEARCH; Volume70PageS13-S20Supplement1; DOI10.33549/physiolres.934780; NOV 2021; 8 citácií

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years

APVV-23-0557 - Signaling pathways of miRNA and ICD proteins in the human ischemic heart.

OPII-VA/DP/2021/10.1-01 - Call for applications for a non-refundable financial contribution to support research capacities and competencies in research and development within the University Science Parks and Research Centers in the Bratislava Region Increasing the capacities and competencies of Comenius University in research, development and innovation (USCCCORD); Code ŽoNFP:NFP313020BUZ3

FaF UK/25/2020 - Musculoskeletal aging and the importance of specific biomarkers in clinical complications of osteoporosis (Klotho, FGF23, MiRNA).

UK/361/2019 - Identification of the presence of specific microRNAs in patients with osteoporosis and heart failure.

Name and surname:	PharmDr. Simona Valášková, PhD.
Document type:	Research/art/teacher profile of a person
The name of the university:	Comenius University Bratislava
The seat of the university:	Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

II. - Higher education and further qualification growth

II.1 - First degree of higher education

II.2 - Second degree of higher education

II.3 - Third degree of higher education

II.4 - Associate professor

II.5 - Professor

II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

IV. - Development of pedagogical, professional, language, digital and other skills

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes

V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year

V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year

V.4 - Overview of supervised final theses

V.4.1 - Number of currently supervised theses

V.4.2 - Number of defended theses

V.5 - Overview of other courses taught in the current academic year according to study programmes

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations

VI.1.1 - Number of the research/artistic/other outputs

VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases

VI.1.3 - Number of citations corresponding to the research/artistic/other outputs

VI.1.4 - Number of citations registered in the Web of Science or Scopus databases

VI.1.5 - Number of invited lectures at the international, national level

VI.2 - The most significant research/artistic/other outputs

VI.3 - The most significant research/artistic/other outputs over the last six years

VI.4 - The most significant citations corresponding to the research/artistic/other outputs

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

IX. - Other relevant facts